Objective
Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival. Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood. This will eventually allow earlier cancer diagnosis, precise monitoring and personalized treatment of patients with cancer. 200,000 lives could be saved every year in Europe with such an earlier diagnosis tool.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
You need to log in or register to use this function
Keywords
Programme(s)
- HORIZON.3.2 - European innovation ecosystems Main Programme
Funding Scheme
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinator
91058 Evry-Courcouronnes
France
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.